default author photo

Lisa Miorin

QBI Coronavirus Research Group (QCRG)

San Francisco, CA 94158

United States

Mount Sinai Health System - Department of Microbiology

New York, NY 10029

United States

Mount Sinai Health System - Global Health and Emerging Pathogens Institute

New York, NY

United States

SCHOLARLY PAPERS

4

DOWNLOADS

326

TOTAL CITATIONS

4

Scholarly Papers (4)

1.

SARS-CoV-2 Variants Evolve Convergent Strategies to Remodel the Host Response

Number of pages: 64 Posted: 15 Jan 2023
University of California, Los Angeles (UCLA) - Department of Microbiology, Immunology and Molecular Genetics, QBI Coronavirus Research Group (QCRG), University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, QBI Coronavirus Research Group (QCRG), Gladstone Institutes - Gladstone Institute of Data Science and Biotechnology, Texas Biomedical Research Institute, QBI Coronavirus Research Group (QCRG), University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, Gladstone Institutes - Gladstone Institute of Data Science and Biotechnology, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, MRC-University of Glasgow Centre for Virus Research, MRC-University of Glasgow Centre for Virus Research, MRC-University of Glasgow Centre for Virus Research, Gladstone Institutes - Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes - Gladstone Institute of Data Science and Biotechnology, Tel Aviv University - School of Computer Sciences, Tel Aviv University - School of Electrical Engineering, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), Wellcome Genome Campus - European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, Mount Sinai Health System - Huffington Center for Cell-based Research in Parkinson's Disease, Mount Sinai Health System - Huffington Center for Cell-based Research in Parkinson's Disease, Synthego Corporation, Synthego Corporation, Synthego Corporation, Synthego Corporation, Synthego Corporation, Synthego Corporation, Synthego Corporation, PharmaMar, S.A., PharmaMar, S.A., PharmaMar, S.A., University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, Massachusetts Institute of Technology (MIT) - MIT Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology (MIT) - MIT Computer Science and Artificial Intelligence Laboratory, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, University College London - Division of Infection and Immunity, QBI Coronavirus Research Group (QCRG), Tel Aviv University - School of Computer Sciences, QBI Coronavirus Research Group (QCRG), Texas Biomedical Research Institute, MRC-University of Glasgow Centre for Virus Research, MRC-University of Glasgow Centre for Virus Research, QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), University of California, San Francisco (UCSF) - Quantitative Biosciences Institute, QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG)Gladstone Institutes - Gladstone Institute of Data Science and Biotechnology and Independent
Downloads 182 (428,796)

Abstract:

Loading...

SARS-CoV-2, variants, virus-host interactions, innate immunity, protein-protein interactions, proteomics, transcriptomics, systems biology.

2.

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

Number of pages: 40 Posted: 03 Sep 2020
Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Kyoto University - Department of Drug Discovery for Lung Diseases, Kyoto University - Department of Drug Discovery for Lung Diseases, National Institute of Infectious Diseases - Department of Veterinary Science, Kyoto University - Department of Drug Discovery for Lung Diseases, QBI Coronavirus Research Group (QCRG), Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford-Burnham Medical Research Institute - Functional Genomics Core, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Northwestern University - Divisions of Infectious Diseases, QBI Coronavirus Research Group (QCRG) and Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program
Downloads 69 (883,195)
Citation 3

Abstract:

Loading...

Innate immunity, SARS-CoV-2, COVID-19, innate immune signaling, pattern recognition receptors

3.

Hepatitis C Virus Drugs Simeprevir And Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV2 Replication

Number of pages: 68 Posted: 03 Dec 2020
Rensselaer Polytechnic Institute (RPI) - Department of Chemistry and Chemical Biology, Mount Sinai Health System - Department of Microbiology, Rensselaer Polytechnic Institute (RPI) - Department of Biological Sciences, QBI Coronavirus Research Group (QCRG), Rensselaer Polytechnic Institute (RPI) - Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute (RPI) - Department of Chemistry and Chemical Biology, Mount Sinai Health System - Department of Microbiology, QBI Coronavirus Research Group (QCRG), QBI Coronavirus Research Group (QCRG), Rensselaer Polytechnic Institute (RPI) - Department of Biological Sciences, QBI Coronavirus Research Group (QCRG), University of Texas at Austin - Department of Molecular Biosciences and Rutgers University, Piscataway - Department of Biochemistry and Molecular Biology
Downloads 40 (1,183,237)

Abstract:

Loading...

COVID-19, SARS-CoV-2 3CL/Mpro Protease, SARS-CoV-2 PL Protease, 33 HCV protease inhibitors, molecular docking, SARS-CoV-2 virus replication, synergism, remdesivir, antivirals

4.

Functional Landscape of SARS-CoV-2 Cellular Restriction

Number of pages: 59 Posted: 13 Oct 2020
Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Drug Design Data Resource, University of California, San Diego (UCSD) - Center for Computational Biology and Bioinformatics, University of California, San Diego (UCSD) - Department of Medicine, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Dermatology, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, QBI Coronavirus Research Group (QCRG), Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine - Department of Microbiology, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Department of Medicine, University of Maryland, Baltimore County (UMBC) - Department of Microbiology and Immunology, QBI Coronavirus Research Group (QCRG), University of California, San Diego (UCSD) - Department of Medicine, Northwestern University - Division of Infectious Diseases, University of California, San Diego (UCSD) - Department of Medicine and Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program
Downloads 35 (1,249,711)
Citation 1

Abstract:

Loading...